Oncotarget: CEA as a blood-based biomarker in anal cancer
CEA is not associated with survival outcomes in SCCA, and is not a clinically relevant biomarker in this disease
2021-07-14
(Press-News.org) Oncotarget published "CEA as a blood-based biomarker in anal cancer" which reported that the mean Carcinoembryonic Antigen (CEA) among subgroups by clinical status at the time of presentation to our institution was highest among those patients with metastatic Squamous cell carcinoma of the anal canal (SCCA) to visceral organs, however this finding was not statistically significant by ANOVA .
By clinical subgroup, the percentage of patients with an abnormally elevated CEA was highest in those patients with metastatic disease to lymph nodes followed by recurrent/unresectable SCCA , and metastatic SCCA to visceral organs, and was statistically significant between groups.
Using RECIST criteria for tumor progression and disease response, the mean change in CEA for patients with progression was an increase in 19 ng/mL, compared to a change of –7.3 ng/mL in those with disease response.
The authors likewise assessed whether CEA levels were associated with survival outcomes for all patients with metastatic SCCA, and found no correlation between CEA and likelihood for survival in a ROC analysis.
Despite interesting patterns of abnormally high CEA in SCCA patients with advanced disease, and correlation of increased CEA with disease progression, CEA is not associated with survival outcomes in SCCA, and is not a clinically relevant biomarker in this disease.
CEA is not associated with survival outcomes in SCCA, and is not a clinically relevant biomarker in this disease
Dr. Van K. Morris from The University of Texas - MD Anderson Cancer Center said, "Squamous cell carcinoma of the anal canal (SCCA) is a rare cancer of the anogenital track with an estimated incidence of about 8500 new cases and 1350 deaths in 2020 in the U.S. annually, comprising 2–3% of all gastrointestinal malignancies."
Routine, readily available blood-based markers are often utilized in the clinical management of patients with solid tumors across a variety of clinical settings.
For example, trends in biomarkers such as carcinoembryonic antigen, carbohydrate antigen 19-9, prostate-specific antigen and carbohydrate antigen 125 can be monitored serially over time for patents with colorectal cancer, pancreatic cancer, prostate cancer, and ovarian cancer, respectively, as a surrogate for changes in amount of tumor present.
To date, no blood-based biomarker for tracking responses to HPV-associated cancers is readily available to clinical oncologists for routine use.
Among anal cancer patients, one series examined 106 patients with early-stage SCCA treated definitely with chemoradiation and did not find clinical utility in the measurement of CEA in this subset of patients with anal cancer.
Since no blood-based biomarkers are currently available in a CLIA-certified laboratory for the routine management of SCCA, we performed a retrospective, single-institution study to correlate serum CEA levels with clinical and pathologic outcomes in patients across all stages and presentations of SCCA.
The Morris Research Team concluded in their Oncotarget Research Output, "we report the largest series to describe CEA as a serum biomarker for patients with metastatic SCCA. Our findings may not provide definitive support for the use of a routinely used blood-based assay for management of patients with SCCA and should guide clinicians in seeking alternative approaches for tracking responses to treatment in this disease. Nonetheless, novel approaches with serum biomarkers are needed for patients with this rare but increasingly diagnosed malignancy."
INFORMATION:
DOI - https://doi.org/10.18632/oncotarget.27959
Full text - https://www.oncotarget.com/article/27959/text/
Correspondence to - Van K. Morris - vkmorris@mdanderson.org
Keywords -
carcinoembryonic antigen,
squamous cell carcinoma of anal canal,
anal cancer,
biomarkers,
HPV
About Oncotarget
Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.
To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with:
SoundCloud - https://soundcloud.com/oncotarget
Facebook - https://www.facebook.com/Oncotarget/
Twitter - https://twitter.com/oncotarget
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/
Oncotarget is published by Impact Journals, LLC please visit https://www.ImpactJournals.com or connect with @ImpactJrnls
Media Contact
MEDIA@IMPACTJOURNALS.COM
18009220957x105
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2021-07-14
New research published online in the International Journal of Mental Health and Addiction found that Canadians with a history of drug dependence are much less likely to have flourishing mental health and are more likely to have mental illness.
Researchers compared a nationally representative sample of 460 Canadians with a history of illicit drug dependence (excluding cannabis) to 20,305 Canadians with no history of illicit drug dependence using data drawn from Statistic Canada's Canadian Community Health Survey-Mental Health.
While 80% of those with a history of drug dependence were in remission, more than half (52.1%) were still experiencing mental illness. Further, only 37.9% were in excellent mental health, which is markedly lower than the 74.1% of ...
2021-07-14
Unlike other population-level stressful events such as natural disasters, COVID-19 has not resulted in a net increase in smoking, according to a new study from the International Tobacco Control (ITC) Project, at the University of Waterloo.
The researchers also found that although nearly half of smokers reported that COVID-19 made them think about quitting, the vast majority of smokers did not change their smoking habits during the early phase of the COVID-19 pandemic.
Led by Shannon Gravely, research assistant professor with the ITC Project, the study ...
2021-07-14
Before Millennials were over laugh-cry emojis, they were the most used emojis across the world, according to researchers at USC. The emoji was more popular than smiley faces say researchers who categorized millions of tweets across 30 countries and evaluated over 1700 emojis. Their study, "An empirical study of emoji usage on Twitter in linguistic and national contexts" was published in Online Social Networks and Media.
Mayank Kejriwal, a research assistant professor in the Department of Industrial and Systems Engineering, and a research lead at the USC Information Sciences Institute who is the lead author on the paper, says approximately 100 emojis are used most often.
The most important take away? Emojis represent ...
2021-07-14
A new study by researchers at Queen Mary University of London, University of Oxford, Institute for Advanced Studies, Vienna, and the Medical University of Graz, has found that lateral flow tests detect Covid-19 with similar accuracy to laboratory-based PCR tests, providing they are used at the onset of infection and soon after symptoms start.
Lateral flow tests are cheaper and produce a result in just 30 minutes - much faster than the time it takes to receive a PCR test result, which can take 1-3 days. The finding could be pivotal to national strategies ...
2021-07-14
A team of geneticists and archaeologists from Ireland, France, Iran, Germany, and Austria has sequenced the DNA from a 1,600-year-old sheep mummy from an ancient Iranian salt mine, Chehrābād. This remarkable specimen has revealed sheep husbandry practices of the ancient Near East, as well as underlining how natural mummification can affect DNA degradation.
The incredible findings have just been published in the international, peer-reviewed journal Biology Letters.
The salt mine of Chehrābād is known to preserve biological material. Indeed, it is in this mine that human remains of the famed "Salt Men" were recovered, dessicated by the salt-rich environment. The ...
2021-07-14
Survival for a baby born with a birth defect - otherwise known as a congenital anomaly - is a "post-code lottery", according to scientists from 74 countries.
A study published today in The Lancet, led by researchers from King's College London, examined the risk of mortality for nearly 4000 babies born with birth defects in 264 hospitals around the world. The study found babies born with birth defects involving the intestinal tract have a two in five chance of dying in a low-income country compared to one in five in a middle-income country and one in twenty in a high-income country.
Gastroschisis, a birth defect where the baby is born with ...
2021-07-14
A global study provides up-to-date estimates for the effect of alcohol consumption on cancers worldwide. It suggests that 4% of all newly diagnosed cancers in 2020 may be associated with drinking alcohol, with men accounting for more than three quarters of those cases.
Risky and heavy drinking was estimated to contribute the highest number of cancer cases, but moderate drinking - the equivalent of around two daily drinks - was estimated to lead to more than 103,000 cases in 2020, almost 1 in 7 of all alcohol-associated cases.
The proportion of new cancer cases associated with alcohol varied widely between world regions, with the lowest found in Northern Africa and Western Asia, and the highest in ...
2021-07-14
COVID-19 is marked by heightened inflammation and abnormal clotting in the blood vessels, particularly in the lungs, and is believed to contribute to progression to severe disease and death. New trial results show that administering a full dose of a standard blood thinner early to moderately ill hospitalized patients with COVID-19 could halt the thrombo-inflammation process and reduce the risk of severe disease and death.
The study, led by investigators at St. Michael's Hospital, a site of Unity Health Toronto, and the University of Vermont Larner College of Medicine, is available as ...
2021-07-14
A scientific team has shown that the release of neurotransmitters in the brain is impaired in patients with schizophrenia who have a rare, single-gene mutation known to predispose people to a range of neurodevelopmental disorders.
Significantly, the results from the research with human-derived neurons validated previous and new experiments that found the same major decrease in neurotransmitter release and synaptic signaling in genetically engineered human neurons with the same genetic variant - the deletion of neurexin 1 (NRXN1). NRXN1 is a protein-coding gene at the synapse, a cellular junction that ...
2021-07-14
WACO, Texas (July 13, 2021) - Climate change mitigation efforts have led to shifts from fossil-fuel dependence to large-scale renewable energy. However, renewable energy sources require significant land and could come at a cost to ecosystems. A new study led by Ryan McManamay, Ph.D., assistant professor of environmental science at Baylor University, evaluates potential conflicts between alternative energy strategies and biodiversity conservation.
The study, published in Biological Conservation, evaluates potential tradeoffs between climate benefits ...
LAST 30 PRESS RELEASES:
[Press-News.org] Oncotarget: CEA as a blood-based biomarker in anal cancer
CEA is not associated with survival outcomes in SCCA, and is not a clinically relevant biomarker in this disease
